EyePoint Pharmaceuticals Inc (NAS:EYPT)
$ 11.11 -0.05 (-0.45%) Market Cap: 578.66 Mil Enterprise Value: 284.98 Mil PE Ratio: 0 PB Ratio: 2.22 GF Score: 55/100

EyePoint Pharmaceuticals Inc at Benzinga Healthcare Small Cap Conference (Virtual) Transcript

Sep 30, 2021 / 03:55PM GMT
Release Date Price: $10.42 (+1.36%)
Brent Slava
Benzinga - Media

All right, next up. We are ready to go with the next one, ladies and gentlemen. We have EyePoint Pharmaceuticals. It is ticker EYPT, and we have the CEO, who is about to come on here in a second, Nancy Lurker. Nancy, are you out there?

Nancy Lurker
EyePoint Pharmaceuticals, Inc. - President & CEO

Hi.

Brent Slava
Benzinga - Media

Hi.

Nancy Lurker
EyePoint Pharmaceuticals, Inc. - President & CEO

Can you see me? Because I'm sharing my screen, but I can see you guys.

Brent Slava
Benzinga - Media

I can see you. You look great, you sound great, I'll let you have the floor.

Nancy Lurker
EyePoint Pharmaceuticals, Inc. - President & CEO

Okay, great. Can you just remind me, just quickly, how much time I have, because I want to try to stay on time here.

Brent Slava
Benzinga - Media

Yes, I really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot